Tech Center 1600 • Art Units: 1611 1614 1628
This examiner grants 26% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17852032 | IONIC LIQUIDS FOR INTERNAL DELIVERY | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17298060 | TOPICAL ANTIMICROBIAL MICROEMULSIONS | Final Rejection | 3M INNOVATIVE PROPERTIES COMPANY |
| 17715447 | COMPOSITION OF AZELAIC ACID HAVING ADIPOSE TRIGLYCERIDE HYDROLYSIS EFFECT | Final Rejection | Korea University Research and Business Foundation |
| 18870803 | EDIBLE FILM AND METHOD FOR MANUFACTURING EDIBLE FILM | Non-Final OA | NISSHA CO., LTD. |
| 17614267 | COMPOSITION AND METHOD FOR ENHANCING SPORE GERMINATION AND BIOLOGICAL EFFICACY | Final Rejection | DANSTAR FERMENT AG |
| 17358920 | STABILIZED FORMULATIONS OF CNS COMPOUNDS | Non-Final OA | Supernus Pharmaceuticals, Inc. |
| 17098324 | MULTIMODAL COMPOSITIONS AND METHODS OF TREATMENT | Non-Final OA | AQUESTIVE THERAPEUTICS, INC. |
| 16967990 | NOVEL PAENIBACILLUS POLYMYXA AND USES THEREOF | Final Rejection | VALAGRO S.P.A. |
| 17921540 | SOLID AND LIQUISOLID FORMULATIONS OF CORALLOPYRONIN A | Final Rejection | RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN |
| 17633973 | ENZYME INHIBITORS | Non-Final OA | KALVISTA PHARMACEUTICALS LIMITED |
| 17937778 | RADIATION SENSITIVITY ENHANCING COMOPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | Non-Final OA | KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES |
| 17050462 | RADIATION SENSITIVITY ENHANCING COMPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | Final Rejection | KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES |
| 17792863 | TOPICAL FORMULATION CONTAINING RAPAMYCIN | Final Rejection | NOBELPHARMA CO., LTD. |
| 16973986 | BIO-HERBICIDE BASED ON ESSENTIAL OIL | Non-Final OA | Université de Liège |
| 18106084 | COMPOSITIONS AND METHODS FOR TREATING PAIN AND/OR INFLAMMATION | Non-Final OA | Neumentum, Inc. |
| 17791700 | METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A DIPEPTIDYL PEPTIDASE 4 INHIBITOR | Non-Final OA | Resverlogix Corp. |
| 17995220 | THE USE OF DIFFUSION ENHANCING COMPOUNDS FOR TREATMENT OF VIRAL AND BACTERIAL INDUCED RESPIRATORY DISEASE | Non-Final OA | DIFFUSION PHARMACEUTICALS LLC |
| 17790145 | TWO-DIMENSIONAL (2D) NANOCOMPOSITE, PREPARATION METHOD, AND USE THEREOF | Final Rejection | Ningbo Cixi Institute of BioMedical Engineering |
| 17781006 | HIGH-STRENGTH MEDICAL FIBER COMPOSITE MATERIAL | Non-Final OA | CHANGZHOU INSTITUTE OF TECHNOLOGY |
| 17665662 | DOSING REGIMEN OF SEDATIVE | Final Rejection | PAION UK LIMITED |
| 17520763 | Photosensitive Dyes and Method of Using Said Dyes | Final Rejection | STRT LLC |
| 17279555 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NITM AND MEDICAL USE THEREOF | Final Rejection | SHENYANG XiNGQi PHARMACEUTICAL CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy